Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

被引:12
|
作者
Ford, Emily S. [1 ,2 ]
Mayer-Blackwell, Koshlan [2 ]
Jing, Lichen [1 ]
Laing, Kerry J. [1 ]
Sholukh, Anton M. [2 ]
Germain, Russell St. [2 ]
Bossard, Emily L. [2 ]
Xie, Hong [3 ]
Pulliam, Thomas H. [1 ]
Jani, Saumya [1 ,3 ]
Selke, Stacy [3 ]
Burrow, Carlissa J. [1 ]
McClurkan, Christopher L. [1 ]
Wald, Anna [1 ,2 ,3 ,4 ]
Greninger, Alexander L. [2 ,3 ]
Holbrook, Michael R. [5 ]
Eaton, Brett [5 ]
Eudy, Elizabeth [5 ]
Murphy, Michael [5 ]
Postnikova, Elena [5 ]
Robins, Harlan S. [6 ]
Elyanow, Rebecca [6 ]
Gittelman, Rachel M. [6 ,10 ]
Ecsedi, Matyas [7 ,11 ]
Wilcox, Elise [7 ]
Chapuis, Aude G. [1 ,7 ]
Fiore-Gartland, Andrew [2 ]
Koelle, David M. [1 ,2 ,3 ,8 ,9 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA 98195 USA
[3] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA USA
[5] Natl Inst Allergy & Immunol, Integrated Res Facil Frederick, Integrated Res Facil, NIH, Frederick, MD 21702 USA
[6] Adapt Biotechnol, Seattle, WA USA
[7] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA USA
[8] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[9] Benaroya Res Inst, Dept Translat Immunol, Seattle, WA 98101 USA
[10] Guardant Hlth, Redwood City, CA USA
[11] Takeda Oncol, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
REACTIVITY; EPITOPES; ANTIGENS; IMMUNITY;
D O I
10.1038/s41590-023-01692-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more protective than vaccination or previous infection alone. To investigate the kinetics of spike-reactive T (T-S) cells from SARS-CoV-2 infection through messenger RNA vaccination in persons with hybrid immunity, we identified the T cell receptor (TCR) sequences of thousands of index T-S cells and tracked their frequency in bulk TCR beta repertoires sampled longitudinally from the peripheral blood of persons who had recovered from coronavirus disease 2019 (COVID-19). Vaccinations led to large expansions in memory T-S cell clonotypes, most of which were CD8(+) T cells, while also eliciting diverse T-S cell clonotypes not observed before vaccination. TCR sequence similarity clustering identified public CD8(+) and CD4(+) TCR motifs associated with spike (S) specificity. Synthesis of longitudinal bulk ex vivo single-chain TCR beta repertoires and paired-chain TCR alpha beta sequences from droplet sequencing of T-S cells provides a roadmap for the rapid assessment of T cell responses to vaccines and emerging pathogens.
引用
收藏
页码:166 / 177
页数:34
相关论文
共 50 条
  • [1] SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
    Bertoletti, Antonio
    Le Bert, Nina
    Tan, Anthony T.
    IMMUNITY, 2022, 55 (10) : 1764 - 1778
  • [2] Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects
    Gallerani, Eleonora
    Proietto, Davide
    Dallan, Beatrice
    Campagnaro, Marco
    Pacifico, Salvatore
    Albanese, Valentina
    Marzola, Erika
    Marconi, Peggy
    Caputo, Antonella
    Appay, Victor
    Gavioli, Riccardo
    Nicoli, Francesco
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] SARS-CoV-2-specific T cells in infection and vaccination
    Bertoletti, Antonio
    Le Bert, Nina
    Qui, Martin
    Tan, Anthony T.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (10) : 2307 - 2312
  • [4] A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
    Lim, Joey Ming Er
    Hang, Shou Kit
    Hariharaputran, Smrithi
    Chia, Adeline
    Tan, Nicole
    Lee, Eng Sing
    Chng, Edwin
    Lim, Poh Lian
    Young, Barnaby E.
    Lye, David Chien
    Le Bert, Nina
    Bertoletti, Antonio
    Tan, Anthony T.
    CELL REPORTS MEDICINE, 2022, 3 (11)
  • [5] Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination
    Salgado Del Riego, Estefania
    Laura Saiz, Maria
    Corte-Iglesias, Viviana
    Leoz Gordillo, Blanca
    Martin-Martin, Cristina
    Rodriguez-Perez, Mercedes
    Escudero, Dolores
    Lopez-Larrea, Carlos
    Suarez-Alvarez, Beatriz
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy
    Jung, Keunok
    Ko, Deok-Han
    Jang, Jeong-Yun
    Kim, Young Rong
    Heo, Jung Yeon
    Kim, Yong-Sung
    CANCER COMMUNICATIONS, 2024, 44 (01) : 173 - 177
  • [7] Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells
    Chen, Mengfei
    Venturi, Vanessa
    Munier, C. Mee Ling
    BIOLOGY-BASEL, 2023, 12 (07):
  • [8] High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19
    Schub, David
    Klemis, Verena
    Schneitler, Sophie
    Mihm, Janine
    Lepper, Philipp M.
    Wilkens, Heinrike
    Bals, Robert
    Eichler, Hermann
    Gartner, Barbara C.
    Becker, Soren L.
    Sester, Urban
    Sester, Martina
    Schmidt, Tina
    JCI INSIGHT, 2020, 5 (20)
  • [9] Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
    Neidleman, Jason
    Luo, Xiaoyu
    George, Ashley F.
    McGregor, Matthew
    Yang, Junkai
    Yun, Cassandra
    Murray, Victoria
    Gill, Gurjot
    Greene, Warner C.
    Vasquez, Joshua
    Lee, Sulggi
    Ghosn, Eliver
    Lynch, Kara
    Roan, Nadia R.
    CELL REPORTS, 2021, 36 (03):
  • [10] Potency assessment of IFN?-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects
    Gil-Bescos, Ruben
    Ostiz, Ainhoa
    Zalba, Saioa
    Tamayo, Ibai
    Bandres, Eva
    Rojas-de-Miguel, Elvira
    Redondo, Margarita
    Zabalza, Amaya
    Ramirez, Natalia
    LIFE SCIENCE ALLIANCE, 2023, 6 (06)